However, recent data suggest that high expression of NOS2 in cancer cells often predicts poor outcomes, such as high expression in breast cancer (21), lung cancer (22),gliomas (23) and colon cancer (24).Shao et al. Here, NOS2 is linked to lung carcinoma.